What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Neuron
- Dopamine
Zhiming Zhang focuses on Glial cell line-derived neurotrophic factor, Dopamine, Internal medicine, Endocrinology and Globus pallidus.
His studies deal with areas such as Substantia nigra, Neuroscience, Putamen and Pharmacology as well as Glial cell line-derived neurotrophic factor.
As part of one scientific family, Zhiming Zhang deals mainly with the area of Substantia nigra, narrowing it down to issues related to the Caudate nucleus, and often Neurochemical.
His Dopamine research focuses on MPTP in particular.
His MPTP study integrates concerns from other disciplines, such as GDNF family of ligands, Neurturin, Cerebral dopamine neurotrophic factor and Parkinsonism.
His Globus pallidus research is multidisciplinary, incorporating elements of Levodopa, Dopaminergic and Striatum.
His most cited work include:
- Functional recovery in parkinsonian monkeys treated with GDNF. (877 citations)
- Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease (288 citations)
- Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys (259 citations)
What are the main themes of his work throughout his whole career to date?
Neuroscience, Dopamine, Substantia nigra, Endocrinology and Internal medicine are his primary areas of study.
His Neuroscience research focuses on subjects like Senescence, which are linked to Physiology.
His Dopamine study incorporates themes from Glial cell line-derived neurotrophic factor, Neurturin, Parkinson's disease and Midbrain.
His Glial cell line-derived neurotrophic factor research includes themes of Ventral tegmental area, Pharmacology, Parkinsonism and Neuron.
Zhiming Zhang has included themes like Basal ganglia, Globus pallidus and Putamen in his Substantia nigra study.
His Huntingtin study in the realm of Internal medicine interacts with subjects such as Messenger RNA and Triglyceride.
He most often published in these fields:
- Neuroscience (49.37%)
- Dopamine (45.57%)
- Substantia nigra (35.44%)
What were the highlights of his more recent work (between 2014-2021)?
- Parkinson's disease (26.58%)
- Putamen (32.91%)
- Neuroscience (49.37%)
In recent papers he was focusing on the following fields of study:
Zhiming Zhang spends much of his time researching Parkinson's disease, Putamen, Neuroscience, Endocrinology and Internal medicine.
His research in Parkinson's disease intersects with topics in Striatum and Dopamine.
Zhiming Zhang specializes in Dopamine, namely MPTP.
His Putamen study combines topics from a wide range of disciplines, such as Basal ganglia, Convection-Enhanced Delivery and Surgery.
His research integrates issues of Substantia nigra and Caudate nucleus in his study of Basal ganglia.
His work on Diabetes mellitus, Metabolic disorder and Clinical chemistry as part of general Endocrinology research is often related to Triglyceride, thus linking different fields of science.
Between 2014 and 2021, his most popular works were:
- Decreased mitochondrial bioenergetics and calcium buffering capacity in the basal ganglia correlates with motor deficits in a nonhuman primate model of aging. (33 citations)
- Onset Time and Durability of Huntingtin Suppression in Rhesus Putamen After Direct Infusion of Antihuntingtin siRNA. (28 citations)
- GDNF revisited: A novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution. (16 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Neuron
- Central nervous system
Zhiming Zhang mainly focuses on Distribution, Parkinson's disease, Internal medicine, Putamen and Endocrinology.
The study incorporates disciplines such as Glial cell line-derived neurotrophic factor, Neurturin, Neuroprotection and Dopamine in addition to Distribution.
Zhiming Zhang has researched Parkinson's disease in several fields, including Basal ganglia and Neuroscience, Neuron.
He integrates Internal medicine with Messenger RNA in his research.
His Substantia nigra research extends to the thematically linked field of Putamen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
